COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions
- 31 December 2025
- journal article
- review article
- Published by SAGE Publications in Viral Immunology
- Vol. 38 (9-10) , 303-316
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.Keywords
This publication has 121 references indexed in Scilit:
- Lactate-induced macrophage HMGB1 lactylation promotes neutrophil extracellular trap formation in sepsis-associated acute kidney injuryCell Biology and Toxicology, 2025
- How to make the best of NLRP3 inhibitors in patients with COVID-19?European Journal of Clinical Pharmacology, 2023
- Transcriptional dynamics of granulocytes in direct response to incubation with SARS‐CoV ‐2FEBS Open Bio, 2022
- The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19Inflammation Research, 2022
- Ixekizumab Successfully Treated Severe Pityriasis Rubra Pilaris after COVID-19 VaccinationSkin Health and Disease, 2022
- Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategiesSeminars in Immunopathology, 2021
- Neurological and psychiatric presentations associated with COVID-19European Archives of Psychiatry and Clinical Neuroscience, 2021
- Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patientsJournal of Hematopathology, 2020
- Distinguishing between COVID‐19 and influenza during the early stages by measurement of peripheral blood parametersJournal of Medical Virology, 2020
- The neutrophil subset defined by CD177 expression is preferentially recruited to gingival crevicular fluid in periodontitisJournal of Leukocyte Biology, 2020